Better Coronavirus Stock: Sorrento Therapeutics vs. Regeneron
In case you haven't noticed, antibody therapies are all the rage when it comes to developing potential treatments for COVID-19. Two companies in the thick of the race with experimental novel-coronavirus antibody therapies are Sorrento Therapeutics (NASDAQ: SRNE) and Regeneron Pharmaceuticals (NASDAQ: REGN).
Both biotech stocks have been big winners so far in 2020. Sorrento's shares have skyrocketed more than 50%, while Regeneron is up more than 40%. Which of these coronavirus-focused stocks is the better pick for long-term investors?
Image source: Getty Images.
Source Fool.com
